---
title: "Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules | BJDX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288913349.md"
description: "Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules | BJDX Stock News"
datetime: "2026-06-05T16:15:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288913349.md)
  - [en](https://longbridge.com/en/news/288913349.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288913349.md)
---

# Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules | BJDX Stock News

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules | BJDX Stock News

### Related Stocks

- [BJDX.US](https://longbridge.com/en/quote/BJDX.US.md)

## Related News & Research

- [Bluejay Diagnostics Raises $7.7 Million in Private Placement, Issues Pre-Funded and 5-Year Warrants](https://longbridge.com/en/news/289105229.md)
- [Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules | BJDX Stock News](https://longbridge.com/en/news/288455979.md)
- [Bluejay Diagnostics Unveils Private Placement Up To $23.6 Mln; Stock Down](https://longbridge.com/en/news/288522165.md)
- [Bluejay responds to investor on possible therapeutic acquisition while prioritizing Symphony platform execution](https://longbridge.com/en/news/279242759.md)
- [Bluejay 10-K: Net loss $6.85M, operating loss $6.95M; cash through Q3 2026](https://longbridge.com/en/news/278166044.md)